THE DEVELOPMENT OF ELECTRORETINOGRAM ABNORMALITIES AND THE POSSIBLE ROLE OF POLYOL PATHWAY ACTIVITY IN DIABETIC HYPERGLYCEMIA AND GALACTOSEMIA

被引:35
作者
SEGAWA, M
HIRATA, Y
FUJIMORI, S
OKADA, K
机构
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1988年 / 37卷 / 05期
关键词
D O I
10.1016/0026-0495(88)90046-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:454 / 460
页数:7
相关论文
共 34 条
[1]  
AKAGI Y, 1983, INVEST OPHTH VIS SCI, V24, P257
[2]  
ALGVERE P, 1968, ACTA OPHTHALMOL, V46, P993
[3]  
Bergmeyer HU, 1974, METHOD ENZYMAT AN, P1205
[4]   ELECTRORETINOGRAM - ITS COMPONENTS AND THEIR ORIGINS [J].
BROWN, KT .
VISION RESEARCH, 1968, 8 (06) :633-+
[5]   POLYOL ACCUMULATION IN GALACTOSEMIC AND DIABETIC RATS - CONTROL BY AN ALDOSE REDUCTASE INHIBITOR [J].
DVORNIK, D ;
SIMARDDU.N ;
KRAMI, M ;
SESTANJ, K ;
GABBAY, KH ;
KINOSHITA, JH ;
VARMA, SD ;
MEROLA, LO .
SCIENCE, 1973, 182 (4117) :1146-1148
[6]   EXPERIMENTAL GALACTOSEMIA PRODUCES DIABETIC-LIKE RETINOPATHY [J].
ENGERMAN, RL ;
KERN, TS .
DIABETES, 1984, 33 (01) :97-100
[7]  
FROSTLARSEN K, 1983, DIABETOLOGIA, V24, P207
[8]  
FUJIMORI S, IN PRESS J MED CHEM
[9]   NERVE-CONDUCTION DEFECT IN GALACTOSE-FED RATS [J].
GABBAY, KH ;
SNIDER, JJ .
DIABETES, 1972, 21 (05) :295-&
[10]  
GREEN RJ, 1985, DIABETOLOGIA, V28, P104